Literature DB >> 7805768

The phospholipase C activating P2U purinoceptor also inhibits cyclicAMP formation in DDT1 MF-2 smooth muscle cells.

H Sipma1, A den Hertog, A Nelemans.   

Abstract

The P2U purinoceptor mediated effect on cellular cAMP was investigated in DDT1 MF-2 smooth muscle cells. Stimulation of these receptors by ATP or UTP caused a pronounced decrease of about 50% in cellular cAMP levels in forskolin or isoprenaline pretreated cells. This action of the nucleotides was concentration dependent with an IC50 of 9.4 +/- 0.2 microM and 29.0 +/- 0.5 microM for UTP and ATP, respectively and was inhibited by the P2-purinoceptor antagonist suramin. The cAMP level appeared to be modified by intracellular Ca2+, represented by an initial decline in cAMP. Neither inactivation of protein kinase C by staurosporine nor elevated cytoplasmic Ca2+ concentrations interfered with the sustained decrease in cAMP levels induced by ATP or UTP, showing that this effect is not mediated via the phospholipase C pathway known to be activated after P2U purinoceptor stimulation in DDT1 MF-2 cells. Pertussis toxin inhibited the action of these nucleotides on the cellular cAMP level. It can be concluded that the P2U purinoceptor in DDT1 MF-2 cells is coupled to different G-proteins, activating phospholipase C and inhibiting adenylyl cyclase activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805768     DOI: 10.1016/0922-4106(94)90069-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Multiple P2Y receptor subtypes in the apical membranes of polarized epithelial cells.

Authors:  H L McAlroy; S Ahmed; S M Day; D L Baines; H Y Wong; C Y Yip; W H Ko; S M Wilson; A Collett
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Distinct Ca(2+) signalling mechanisms induced by ATP and sphingosylphosphorylcholine in porcine aortic smooth muscle cells.

Authors:  T Y Chin; S H Chueh
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.

Authors:  C Ho; J Hicks; M W Salter
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  P2-purigenic receptors regulate phospholipase C and adenylate cyclase activities in immortalized Schwann cells.

Authors:  L N Berti-Mattera; P L Wilkins; Z Madhun; D Suchovsky
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

5.  Ca(2+)-dependent and -independent mechanism of cyclic-AMP reduction: mediation by bradykinin B2 receptors.

Authors:  H Sipma; A den Hertog; A Nelemans
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

6.  Regulation of histamine- and UTP-induced increases in Ins(1,4,5)P3, Ins (1,3,4,5)P4 and Ca2+ by cyclic AMP in DDT1 MF-2 cells.

Authors:  H Sipma; M Duin; B Hoiting; A den Hertog; A Nelemans
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

7.  Evidence for a discrete UTP receptor in cardiac endothelial cells.

Authors:  S Yang; I L Buxton; C B Probert; J N Talbot; M E Bradley
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.